Skip to content

IBIS PHARMA

Active
Public limited companyfounded 199233 yrs activeGeneraal Wahislaan 20a, 1030 Schaarbeek, BelgiumKBO/BCE: BE 0448.505.234

IBIS PHARMA has been active since 1992 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.95M and a net result of €562k. Equity is growing by ~3.5% per year across the filed fiscal years. Its solvency ranks better than 80% of 4147 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Checked score

Score 2025
76 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability67▼-1
Solvency92▲+15
Growth66▼-10
Track record100
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €300k at 30 days acceptable
Liquidity ample (current ratio 3.28 against 2.09 in 2024; short-term debt: 30.1% and cash: 27.5% of total assets), and 32.9% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Nine signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 33 years 0 40 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
67.1%
Return on assets
9.5%
Age of the figures
9 mo
raises risk · Multiple establishment units
Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.
KBO · establishment units
lowers risk · Lower-risk legal form
Companies with this legal form statistically fail less often than a BV.
KBO · legal form
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 13-07-2026, 18 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
18 d early
2024
65 d early
2023
7 d early
2022
70 d early
2021
27 d early
2020
52 d early
2019
22 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
20-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, full schema

Turnover
€16.91M▼ 5.3%
2024 · €17.86M
2023: €15.96M 2024: €17.86M
2023 → 2025
EBIT margin
4.6%▼ 0.5pp
2024 · 5.1%
2023: 3.8% 2024: 5.1%
2023 → 2025
Net result
€562k▼ 18.0%
2024 · €685k
2018: €450k 2019: €649k 2020: €559k 2021: €700k 2022: €676k 2023: €441k 2024: €685k
2018 → 2025
Working capital
€4.04M▲ 20.6%
2024 · €3.35M
2018: €3.00M 2019: €3.19M 2020: €2.87M 2021: €2.74M 2022: €3.52M 2023: €3.47M 2024: €3.35M
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€15.96M€17.86M▲ 11.9%€16.91M▼ 5.3%
Equity€2.59M-€3.26M▲ 26.1%€3.40M▲ 4.3%€3.39M▼ 0.4%€3.95M▲ 16.6%
Operating result€912k-€851k▼ 6.8%€603k▼ 29.1%€914k▲ 51.5%€775k▼ 15.2%
Net result€700k-€676k▼ 3.4%€441k▼ 34.8%€685k▲ 55.4%€562k▼ 18.0%
Result per fiscal year
Operating resultNet result
€0€250k€500k€750k€1.00MOperating result 2021: €912k€912kNet result 2021: €700k€700kOperating result 2022: €851k€851kNet result 2022: €676k€676kOperating result 2023: €603k€603kNet result 2023: €441k€441kOperating result 2024: €914k€914kNet result 2024: €685k€685kOperating result 2025: €775k€775kNet result 2025: €562k€562k20212022202320242025
The operating result falls in 2025; 2025 is 15% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €5.89M
Fixed assets €75k▼ 35.9%
Current assets €5.81M▼ 9.7%
Equity and liabilities €5.89M
Equity €3.95M▲ 16.6%
Debt €1.94M▼ 38.9%
The debt ratio falls from 48.3% to 32.9%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€798k
2024 · €949k
Cash flow
€585k
2024 · €720k
Solvency
67.1%
2024 · 51.7%
Current ratio
3.28
2024 · 2.09
Quick ratio
1.60
2024 · 1.26
Debt / equity
0.49
2024 · 0.93
ROE
14.2%
2024 · 20.2%
ROA
9.5%
2024 · 10.4%
Interest coverage
6.24
2024 · 19.74
Debt
€1.94M
2024 · €3.17M
Debt ≤ 1 year
€1.77M
2024 · €3.09M
Income taxes
€199k
2024 · €252k
Staff costs
€447k
2024 · €392k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€6.56M€5.89M
Fixed assets21/28€116k€75k
Tangible fixed assets22/27€116k€75k
Plant, machinery and equipment23€516€7k
Furniture and vehicles24€116k€68k
Other tangible fixed assets26€0€0=
Current assets29/58€6.44M€5.81M
Stocks and contracts in progress3€2.55M€2.98M
Stocks30/36€2.55M€2.98M
Goods purchased for resale34€2.55M€2.98M
Amounts receivable within one year40/41€2.76M€1.03M
Trade receivables40€2.74M€995k
Other amounts receivable41€16k€33k
Cash at bank and in hand54/58€945k€1.62M
Deferred charges and accrued income490/1€187k€189k
Equity and liabilities
Total equity and liabilities10/49€6.56M€5.89M
Equity10/15€3.39M€3.95M
Contributions10/11€174k€174k=
Capital10€174k€174k=
Issued capital100€174k€174k=
Reserves13€3.21M€3.78M
Non-distributable reserves130/1€17k€17k=
Legal reserve130€17k€17k=
Distributable reserves133€3.20M€3.76M
Amounts payable17/49€3.17M€1.94M
Amounts payable within one year42/48€3.09M€1.77M
Trade debts44€2.25M€1.72M
Suppliers440/4€2.25M€1.72M
Taxes, remuneration and social security45€136k€54k
Taxes450/3€82k-
Remuneration and social security454/9€54k€54k=
Other amounts payable47/48€700k-
Accrued charges and deferred income492/3€79k€166k
Income statement Code20242025
Operating income70/76A€18.05M€17.04M
Turnover70€17.86M€16.91M
Other operating income74€187k€120k
Non-recurring operating income76A€4k€8k
Operating charges60/66A€17.14M€16.27M
Goods for resale, raw materials and consumables60€16.00M€15.11M
Purchases600/8€16.29M€15.59M
Change in stocks: decrease (increase)609€-287k€-476k
Services and other goods61€699k€651k
Remuneration, social security and pensions62€392k€447k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€35k€23k
Other operating charges640/8€6k€6k
Non-recurring operating charges66A-€30k
Operating profit (loss)9901€914k€775k
Financial income75/76B€71k€113k
Recurring financial income75€71k€113k
Other financial income752/9€71k€113k
Financial charges65/66B€48k€128k
Recurring financial charges65€48k€128k
Other financial charges652/9€48k€128k
Profit (loss) for the period before taxes9903€937k€760k
Income taxes67/77€252k€199k
Taxes670/3€252k€199k
Profit (loss) for the period9904€685k€562k
Profit (loss) for the period to be appropriated9905€685k€562k
Appropriation of the result
Profit (loss) to be appropriated9906€685k€562k
Transfer from equity791/2€15k-
From reserves792€15k-
Transfer to equity691/2-€562k
To other reserves6921-€562k
Profit to be distributed694/7€700k-
Return on contributions (dividend)694€700k-
Social balance
Average headcount (FTE)90876.05.8

The notes to these accounts (36 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
13-07
NBB filing Annual accounts filed
fiscal year 2025 · full schema
2025
27-05
NBB filing Annual accounts filed
fiscal year 2024 · full schema
2024
24-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
31-12
Financial Weakest financial yearnet €441k ▼34.8%
Net result drops to €441k, the lowest in the series; recovery starts the following year.
22-05
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
04-07
NBB filing Annual accounts filed
fiscal year 2021 · full schema
2021
31-12
Financial Highest result since 2018net €700k ▲25.1%
Net result €700k, the highest in the series.
09-06
NBB filing Annual accounts filed
fiscal year 2020 · full schema
2020
09-07
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
27-08
NBB filing Annual accounts filed
fiscal year 2018 · full schema · 27 days late
2018
27-07
NBB filing Annual accounts filed
fiscal year 2017 · full schema
2017
28-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 28 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
7 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Schaarbeek · 2 establishment units since 1992
establishment All 2 establishment units on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Generaal Wahislaan 20a1030 Schaarbeek
Ground area
3,385 m²
Building footprint
763 m²
Volume, LiDAR
14,814 m³
2 parcels, Brussels, Wallonia · tallest building 25.1 m, ±7 floors. Linked by address, not a title deed.
2 establishment units
Rue du Basteau,Forrières 5, 6953 Nassogne
NACE 51460
since 19922.059.479.848
Generaal Wahislaan 20 A, 1030 Schaarbeek
NACE 51460
since 19932.059.479.749
2 parcels
Wallonia 1 (50%) Brussels 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
21904B0384/00M000 Brussels 1,988 m² 1 · 643 m² 25.1 m · 7 fl.
83015B0212/00P000 Wallonia 1,397 m² 1 · 120 m² 9.9 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 1,401 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPublic limited company
Founded27-10-1992
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
47730Retail sale of pharmaceutical products
52310
Sources
Crossroads Bank for EnterprisesNational Bank · 33 filingsAddress and cadastre registers

Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.